Pandemic heats up demand for Seek Thermal’s sensors
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
‘Don’t be afraid of COVID?’ Not buying it unless businee do job right
By Elisabeth Rosenthal, California Healthline As stores, restaurants, airlines and offices try to lure clients back, this is what they need to do to earn my business: Make me feel safe — no, make me be as safe as possible. As I’ve begun to explore old haunts, some are doing a fabulous job. Others are Read More →
Paul Glenn, Montecito investor and philanthropist, dies at 89
Paul F. Glenn, a successful commodities trader whose foundation invested more than $100 million into research related to aging and longevity, has died in Montecito at age 89. He was a native of Pennsylvania who attended Princeton and Harvard Law School before embarking on a career as a commodities trader. Much of his success came Read More →
Ventura County moves into reopening stage that allows gyms, restaurants indoors
Ventura County moved into the second tier of California’s COVID-19 reopening process on Oct. 6, putting all three Central Coast counties in that category. Under the rules for red counties, Ventura County gyms, personal care services, museums, zoos, places of worship, movie theaters and restaurants will be able to reopen indoor operations in a limited Read More →
Arcutis shares up on news of public, private offerings
Arcutis Biotherapeutics saw a 15 percent rise in its share price after it said Sept. 29 that it will offer 4 million shares to the public and sell another $35 million in stock to an affiliate of one of its directors. Arcutis closed at $31.04, a gain of $4.28 after it announced the dual track Read More →
VCMC heals its finances
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Cure closes $20M CBD acquisition
Cure Pharmaceutical, an Oxnard cannabis products manufacturer, has completed its $20 million cash-and-stock buyout of the CBD company Sera Labs, a deal Cure says will help it reach positive cash flow in around 18 months. Cure’s stock, which is traded on the over-the-counter markets, fell 3 percent following the announcement, closing at $1.29 per share Read More →
